Evidence map›Paper›PMID 27052675›Full record

ArticleCritical care (London, England)2016

Characteristics and outcomes of anti-infective de-escalation during health care-associated intra-abdominal infections.

Philippe Montravers, Pascal Augustin, Nathalie Grall, Mathieu Desmard, Nicolas Allou, Jean-Pierre Marmuse, Jean Guglielminotti

Open access · goldAbstract read
In one paragraph

Article in Critical care (London, England), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Antimicrobial De-Escalation in Critically Ill Patients.Antibiotics (Basel, Switzerland) · 2024
    Review
  3. Optimized Treatment of Nosocomial Peritonitis.Antibiotics (Basel, Switzerland) · 2023
    Review
  4. Article
  5. Review
  6. Antibiotic De-Escalation in Emergency General Surgery.Antibiotics (Basel, Switzerland) · 2022
    Article
  7. Article
  8. Timing of antibiotic therapy in the ICU.Critical care (London, England) · 2021
    Review
  9. Review
  10. Observational
  11. Observational
  12. Observational
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Philippe MontraversDépartement d'Anesthésie Réanimation, APHP, CHU Bichat-Claude Bernard, Paris, France. philippe.montravers@aphp.fr.
Pascal AugustinDépartement d'Anesthésie Réanimation, APHP, CHU Bichat-Claude Bernard, Paris, France.
Nathalie GrallUniversité Denis Diderot, PRESS Sorbonne Cité, Paris, France.
Mathieu DesmardDépartement d'Anesthésie Réanimation, APHP, CHU Bichat-Claude Bernard, Paris, France.
Nicolas AllouDépartement d'Anesthésie Réanimation, APHP, CHU Bichat-Claude Bernard, Paris, France.
Jean-Pierre MarmuseUniversité Denis Diderot, PRESS Sorbonne Cité, Paris, France.
Jean GuglielminottiDépartement d'Anesthésie Réanimation, APHP, CHU Bichat-Claude Bernard, Paris, France.
Biology of Infection · FRHôpital Bichat-Claude-Bernard · FRCentre Hospitalier Sud Francilien · FRDélégation Paris 7 · FRUniversité Claude Bernard Lyon 1 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDe-escalation is strongly recommended for antibiotic stewardship. No studies have addressed this issue in the context of health care-associated intra-abdominal infections (HCIAI). We analyzed the factors that could interfere with this process and their clinical consequences in intensive care unit (ICU) patients with HCIAI.

methodsAll consecutive patients admitted for the management of HCIAI who survived more than 3 days following their diagnosis, who remained in the ICU for more than 3 days, and who did not undergo early reoperation during the first 3 days were analyzed prospectively in an observational, single-center study in a tertiary care university hospital.

resultsOverall, 311 patients with HCIAI were admitted to the ICU. De-escalation was applied in 110 patients (53%), and no de-escalation was reported in 96 patients (47%) (escalation in 65 [32%] and unchanged regimen in 31 [15%]). Lower proportions of Enterococcus faecium, nonfermenting Gram-negative bacilli (NFGNB), and multidrug-resistant (MDR) strains were cultured in the de-escalation group. No clinical difference was observed at day 7 between patients who were de-escalated and those who were not. Determinants of de-escalation in multivariate analysis were adequate empiric therapy (OR 9.60, 95% CI 4.02-22.97) and empiric use of vancomycin (OR 3.39, 95% CI 1.46-7.87), carbapenems (OR 2.64, 95% CI 1.01-6.91), and aminoglycosides (OR 2.31 95% CI 1.08-4.94). The presence of NFGNB (OR 0.28, 95% CI 0.09-0.89) and the presence of MDR bacteria (OR 0.21, 95% CI 0.09-0.52) were risk factors for non-de-escalation. De-escalation did not change the overall duration of therapy. The risk factors for death at day 28 were presence of fungi (HR 2.64, 95% CI 1.34-5.17), Sequential Organ Failure Assessment score on admission (HR 1.29, 95% CI 1.16-1.42), and age (HR 1.03, 95% CI 1.01-1.05). The survival rate expressed by a Kaplan-Meier curve was similar between groups (log-rank test p value 0.176).

conclusionsDe-escalation is a feasible option in patients with polymicrobial infections such as HCIAI, but MDR organisms and NFGNB limit its implementation.

Indexed as

Treatment OutcomeAgedAnti-Bacterial AgentsCritical CareCross InfectionDrug Resistance, MicrobialFemaleHumansIntensive Care UnitsIntraabdominal InfectionsMaleMiddle AgedTime FactorsVancomycinAnti-Bacterial AgentsVancomycinAntibiotic therapyDe-escalationHealth care-associated intra-abdominal infectionsMultidrug-resistant bacteriaPeritonitis

Identifiers

PMID27052675
PMCPMC4823898
OpenAlexW2315581653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.